Thomas Horvatits

3.0k total citations · 1 hit paper
70 papers, 1.9k citations indexed

About

Thomas Horvatits is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Thomas Horvatits has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hepatology, 30 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Thomas Horvatits's work include Liver Disease and Transplantation (48 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis Viruses Studies and Epidemiology (18 papers). Thomas Horvatits is often cited by papers focused on Liver Disease and Transplantation (48 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis Viruses Studies and Epidemiology (18 papers). Thomas Horvatits collaborates with scholars based in Germany, Austria and Belgium. Thomas Horvatits's co-authors include Valentin Fuhrmann, Andreas Drolz, Michael Trauner, Kevin Roedl, Lutz Fischer, Samuel Huber, Klaus Püschel, Matthias Tamminga, Marcial Sebode and Elke Kerstin Fischer and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Thomas Horvatits

67 papers receiving 1.8k citations

Hit Papers

Microplastics detected in cirrhotic liver tissue 2022 2026 2023 2024 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Microplastics detected in cirrhotic liver tissue
    2022 440 citations Thomas Horvatits, Matthias Tamminga et al. EBioMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Horvatits Germany 24 1.0k 708 410 349 216 70 1.9k
Yoichi Matsui Japan 29 733 0.7× 669 0.9× 36 0.1× 1.2k 3.3× 28 0.1× 122 2.6k
Feifei Hou China 15 235 0.2× 221 0.3× 61 0.1× 148 0.4× 25 0.1× 49 774
Ahmet Gürakar United States 30 1.5k 1.5× 1.1k 1.6× 40 0.1× 1.2k 3.4× 2 0.0× 174 2.8k
Ying Guo China 15 65 0.1× 151 0.2× 51 0.1× 81 0.2× 26 0.1× 58 1.0k
Emilio González‐Parra Spain 21 155 0.2× 204 0.3× 34 0.1× 174 0.5× 13 0.1× 86 1.8k
Alastair Watson United Kingdom 17 134 0.1× 373 0.5× 24 0.1× 107 0.3× 60 0.3× 43 1.2k
Su Hyun Kim South Korea 19 32 0.0× 61 0.1× 161 0.4× 163 0.5× 42 0.2× 89 989
Chun‐Chen Yu Taiwan 21 26 0.0× 135 0.2× 84 0.2× 161 0.5× 6 0.0× 39 1.2k
Roberto Alcázar Arroyo Spain 20 80 0.1× 170 0.2× 18 0.0× 199 0.6× 6 0.0× 128 1.5k
Binay K De India 21 637 0.6× 551 0.8× 117 0.3× 352 1.0× 1 0.0× 33 1.5k

Countries citing papers authored by Thomas Horvatits

Since Specialization
Citations

This map shows the geographic impact of Thomas Horvatits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Horvatits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Horvatits more than expected).

Fields of papers citing papers by Thomas Horvatits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Horvatits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Horvatits. The network helps show where Thomas Horvatits may publish in the future.

Co-authorship network of co-authors of Thomas Horvatits

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Horvatits. A scholar is included among the top collaborators of Thomas Horvatits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Horvatits. Thomas Horvatits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roedl, Kevin, et al.. (2025). Impact of acute respiratory distress syndrome on outcome in critically ill patients with liver cirrhosis. Scientific Reports. 15(1). 4301–4301. 1 indexed citations
2.
Schemmerer, Mathias, Hans H. Bock, Jörn M. Schattenberg, et al.. (2024). Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients. Journal of Medical Virology. 96(6). e29735–e29735. 3 indexed citations
3.
4.
Pischke, Sven, Thomas Horvatits, Julian Schulze zur Wiesch, et al.. (2023). Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients. Hepatology. 78(6). 1882–1895. 17 indexed citations
5.
Horvatits, Thomas, Patrick Behrendt, Martina Guthoff, et al.. (2023). Oral Zinc Supplementation in Chronically HEV-Infected Patients Not Responding to Ribavirin Monotherapy. Hepatitis Monthly. 23(1). 1 indexed citations
6.
Pischke, Sven, E. V. Knoop, Adam P. Wagner, et al.. (2023). Anti-HEV seroprevalence and rate of viremia in a German cohort of dogs, cats, and horses. Scientific Reports. 13(1). 19240–19240. 4 indexed citations
7.
Pischke, Sven, Ulrike Peters, Julian Schulze zur Wiesch, et al.. (2023). High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity. Annals of Hepatology. 28(2). 100887–100887. 3 indexed citations
8.
Zöllkau, Janine, Juliane Ankert, Mathias W. Pletz, et al.. (2022). Hepatitis E, Schistosomiasis and Echinococcosis–Prevalence in a Cohort of Pregnant Migrants in Germany and Their Influence on Fetal Growth Restriction. Pathogens. 11(1). 58–58. 2 indexed citations
9.
Horvatits, Thomas, Matthias Tamminga, Beibei Liu, et al.. (2022). Microplastics detected in cirrhotic liver tissue. EBioMedicine. 82. 104147–104147. 440 indexed citations breakdown →
10.
Brehm, Thomas Theo, Omid Mazaheri, Thomas Horvatits, et al.. (2021). Lower Levels of Transaminases but Higher Levels of Serum Creatinine in Patients with Acute Hepatitis E in Comparison to Patients with Hepatitis A. Pathogens. 10(1). 60–60. 9 indexed citations
11.
Fründt, Thorben, Dominik Nörz, Thomas Theo Brehm, et al.. (2021). Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic. PLoS ONE. 16(12). e0258450–e0258450. 2 indexed citations
12.
Horvatits, Thomas, et al.. (2021). Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival. Annals of Hepatology. 26. 100559–100559. 2 indexed citations
13.
Roedl, Kevin, Alexander Spiel, Alexander Nürnberger, et al.. (2019). Hypoxic liver injury after in- and out-of-hospital cardiac arrest: Risk factors and neurological outcome. Resuscitation. 137. 175–182. 23 indexed citations
14.
Hiller, Jens, U Denzer, Susanne Polywka, et al.. (2018). HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients. Journal of Hepatology. 69(1). 36–42. 66 indexed citations
15.
Rutter, Karoline, Thomas Horvatits, Andreas Drolz, et al.. (2018). Akutes Leberversagen. PubMed. 22(1). 38–47. 1 indexed citations
16.
Rutter, Karoline, Monika Ferlitsch, A Maieron, et al.. (2016). von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy. Digestive and Liver Disease. 48(10). 1194–1199. 1 indexed citations
17.
Horvatits, Thomas, Andreas Drolz, Karoline Rutter, Stefan Kluge, & Valentin Fuhrmann. (2014). Pulmonale Komplikationen bei Lebererkrankungen. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 109(4). 235–239. 4 indexed citations
18.
Schwabl, Philipp, B.A. Payer, Jelena Grahovac, et al.. (2014). Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats. Journal of Hepatology. 60(6). 1135–1142. 37 indexed citations
19.
Payer, B.A., Thomas Reiberger, Philipp Schwabl, et al.. (2013). 593 LENALIDOMIDE AMELIORATES THE PORTAL HYPERTENSIVE SYNDROME IN NON-CIRRHOTIC AND CIRRHOTIC PORTAL HYPERTENSIVE ANIMALS. Journal of Hepatology. 58. S242–S243. 1 indexed citations
20.
Horvatits, Thomas & Valentin Fuhrmann. (2013). Therapeutic options in pulmonary hepatic vascular diseases. Expert Review of Clinical Pharmacology. 7(1). 31–42. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoichi Matsui Breakdown of academic impact, for papers by Feifei Hou Breakdown of academic impact, for papers by Ahmet Gürakar Breakdown of academic impact, for papers by Ying Guo Breakdown of academic impact, for papers by Emilio González‐Parra Breakdown of academic impact, for papers by Alastair Watson Breakdown of academic impact, for papers by Su Hyun Kim Breakdown of academic impact, for papers by Chun‐Chen Yu Breakdown of academic impact, for papers by Roberto Alcázar Arroyo Breakdown of academic impact, for papers by Binay K De
Rankless by CCL
2026